ENCORE Introduces Innovative Beverage Mixes Featuring Science-Backed Cognizin ® and IMMUSE™ for Cognitive and Beauty Support

Kyowa Hakko's Cognizin® Citicoline, and postbiotic, IMMUSE™, infuse their cutting-edge components in the new product line. NEW YORK , April 18, 2024 /PRNewswire-PRWeb/ -- Kyowa Hakko U.S.A., Inc. announces the inclusion of its science-backed branded ingredients Cognizin® and IMMUSE™ in...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: PDT Source Type: news